SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1 - General form for registration of securities under the Securities Act of 1933:
SEC Accession No. 0001683168-23-000853
Filing Date
2023-02-14
Accepted
2023-02-15 06:06:41
Documents
47

Document Format Files

Seq Description Document Type Size
1 FORM S-1 coeptis_s1.htm   iXBRL S-1 1979558
2 SUBSIDIARIES OF COEPTIS THERAPEUTICS HOLDINGS, INC. coeptis_ex2101.htm EX-21.1 1513
3 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM coeptis_ex2301.htm EX-23.1 1699
4 CALCULATION OF FILING FEE TABLES coeptis_ex107.htm EX-FILING FEES 19890
10 GRAPHIC image_001.jpg GRAPHIC 6331
  Complete submission text file 0001683168-23-000853.txt   6153354

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE coep-20220930.xsd EX-101.SCH 33563
6 XBRL CALCULATION FILE coep-20220930_cal.xml EX-101.CAL 45133
7 XBRL DEFINITION FILE coep-20220930_def.xml EX-101.DEF 130839
8 XBRL LABEL FILE coep-20220930_lab.xml EX-101.LAB 237437
9 XBRL PRESENTATION FILE coep-20220930_pre.xml EX-101.PRE 200412
41 EXTRACTED XBRL INSTANCE DOCUMENT coeptis_s1_htm.xml XML 854355
Mailing Address 105 BRADFORD ROAD, SUITE 420 WEXFORD PA 15090
Business Address 105 BRADFORD ROAD, SUITE 420 WEXFORD PA 15090 724-934-6467
Coeptis Therapeutics Holdings, Inc. (Filer) CIK: 0001759186 (see all company filings)

IRS No.: 981465952 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1 | Act: 33 | File No.: 333-269782 | Film No.: 23633525
SIC: 2836 Biological Products, (No Diagnostic Substances)